Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 12/2016

01-12-2016 | Original article

RETRACTED ARTICLE: Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma

Authors: Yasan Sadeghian, Zahra Kamyabi-Moghaddam, Seyed Mohamad Hossein Tabatabaei Nodushan, Samaneh Khoshbakht, Behnam Pedram, Emad Yahaghi, Aram Mokarizadeh, Mahdi Mohebbi

Published in: Tumor Biology | Issue 12/2016

Login to get access

Excerpt

RETRACTED ARTICLE: Tumor Biol. …
Appendix
Available only for authorised users
Metadata
Title
RETRACTED ARTICLE: Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma
Authors
Yasan Sadeghian
Zahra Kamyabi-Moghaddam
Seyed Mohamad Hossein Tabatabaei Nodushan
Samaneh Khoshbakht
Behnam Pedram
Emad Yahaghi
Aram Mokarizadeh
Mahdi Mohebbi
Publication date
01-12-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 12/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3799-y

Other articles of this Issue 12/2016

Tumor Biology 12/2016 Go to the issue

Original Article

BRCA1 and MDM2 as independent blood-based biomarkers of head and neck cancer

Original Article

miR-203 is a predictive biomarker for colorectal cancer and its expression is associated with BIRC5

Original Article

PI3K and MAPK pathways mediate the BDNF/TrkB-increased metastasis in neuroblastoma

Original Article

Overexpression of cannabinoid receptor 1 promotes renal cell carcinoma progression

Original Article

Reduced decorin expression in the tumor stroma correlates with tumor proliferation and predicts poor prognosis in patients with I–IIIA non-small cell lung cancer

Original Article

Norcantharidin induces autophagy-related prostate cancer cell death through Beclin-1 upregulation by miR-129-5p suppression
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits